PL1610785T3 - Połączenie farmaceutyczne do leczenia spastyczności i/lub bólu - Google Patents

Połączenie farmaceutyczne do leczenia spastyczności i/lub bólu

Info

Publication number: PL1610785T3
Authority: PL; Poland
Prior art keywords: spasticity; treatment; pain; pharmaceutical combination; combination
Prior art date: 2003-04-09

Application number

PL04726223T

Other languages

English (en)

Inventor

Károly Tihanyi

Pál Kocsis

György Németh

István Tarnawa

Balázs Dalmadi

Original Assignee

Richter Gedeon Vegyeszeti Gyar Rt

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-09

Filing date

2004-04-07

Publication date

2008-01-31

2004-04-07 Application filed by Richter Gedeon Vegyeszeti Gyar Rt filed Critical Richter Gedeon Vegyeszeti Gyar Rt

2008-01-31 Publication of PL1610785T3 publication Critical patent/PL1610785T3/pl

Links

208000008238 Muscle Spasticity Diseases 0.000 title abstract 2
208000018198 spasticity Diseases 0.000 title abstract 2
MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229960001985 dextromethorphan Drugs 0.000 abstract 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Emergency Medicine (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

PL04726223T 2003-04-09 2004-04-07 Połączenie farmaceutyczne do leczenia spastyczności i/lub bólu PL1610785T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
HU0300929A HUP0300929A3 (en)	2003-04-09	2003-04-09	Analgetic and/or muscle relaxant pharmaceutical composition
PCT/HU2004/000032 WO2004089352A2 (en)	2003-04-09	2004-04-07	Pharmaceutical combination for the treatment of spasticity and/or pain
EP04726223A EP1610785B1 (en)	2003-04-09	2004-04-07	Pharmaceutical combination for the treatment of spasticity and/or pain

Publications (1)

Publication Number	Publication Date
PL1610785T3 true PL1610785T3 (pl)	2008-01-31

Family

ID=90001682

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04726223T PL1610785T3 (pl)	2003-04-09	2004-04-07	Połączenie farmaceutyczne do leczenia spastyczności i/lub bólu

Country Status (16)

Country	Link
US (1)	US20060199841A1 (pl)
EP (1)	EP1610785B1 (pl)
JP (1)	JP2006522786A (pl)
AT (1)	ATE370733T1 (pl)
CY (1)	CY1106903T1 (pl)
DE (1)	DE602004008440T2 (pl)
DK (1)	DK1610785T3 (pl)
EA (1)	EA007732B1 (pl)
ES (1)	ES2293245T3 (pl)
HR (1)	HRP20070441T3 (pl)
HU (1)	HUP0300929A3 (pl)
NO (1)	NO20055254L (pl)
PL (1)	PL1610785T3 (pl)
PT (1)	PT1610785E (pl)
RS (1)	RS20050738A (pl)
WO (1)	WO2004089352A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2357808T3 (es) *	2001-06-07	2011-04-29	Christine Dr. Sang	Tratamiento del dolor neuropático con antagonistas del receptor de n-metil-d-aspartato (nmda).
US8262942B2 (en)	2008-02-07	2012-09-11	The George Washington University	Hollow carbon nanosphere based secondary cell electrodes
TR201720289A2 (tr) *	2017-12-13	2019-06-21	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Tolperizon Ve Selektif COX-2 İnhibitörü Kombinasyonları
JP7169580B2 (ja) *	2018-09-27	2022-11-11	株式会社Ｌｔｔバイオファーマ	線維症治療用医薬組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5340779A (en) *	1976-09-21	1978-04-13	Nippon Kayaku Co Ltd	Optically active tolpertisone, their preparation and pharmaceuticals containting the same
US4906638A (en) *	1987-12-22	1990-03-06	Nova Pharmaceutical Corporation	Dextromethorphan potentiator for anticonvulsant composition and method
AU2929489A (en) *	1987-12-22	1989-07-19	John W. FERKANY	Dextrorphan potentiator for anticonvulsant composition and method
US5206248A (en) *	1992-03-27	1993-04-27	Smith Richard A	Method for reducing emotional lability
JP4097285B2 (ja) *	1994-09-22	2008-06-11	リチャード・アラン・スミス	種々の頑固な疾患の治療のための医薬の製造に有用な組成物
US5840731A (en) *	1995-08-02	1998-11-24	Virginia Commonwealth University	Pain-alleviating drug composition and method for alleviating pain
AUPN605795A0 (en) *	1995-10-19	1995-11-09	F.H. Faulding & Co. Limited	Analgesic pharmaceutical composition
CA2264182A1 (en) *	1996-08-23	1998-02-26	Algos Pharmaceutical Corporation	Anticonvulsant containing composition for treating neuropathic pain
AT409083B (de) *	1999-04-01	2002-05-27	Sanochemia Pharmazeutika Ag	Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
DE10123129A1 (de) *	2001-05-02	2002-11-14	Berolina Drug Dev Ab Svedala	Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel

2003
- 2003-04-09 HU HU0300929A patent/HUP0300929A3/hu unknown
2004
- 2004-04-07 ES ES04726223T patent/ES2293245T3/es not_active Expired - Lifetime
- 2004-04-07 RS YUP-2005/0738A patent/RS20050738A/sr unknown
- 2004-04-07 PT PT04726223T patent/PT1610785E/pt unknown
- 2004-04-07 AT AT04726223T patent/ATE370733T1/de not_active IP Right Cessation
- 2004-04-07 EP EP04726223A patent/EP1610785B1/en not_active Expired - Lifetime
- 2004-04-07 DE DE602004008440T patent/DE602004008440T2/de not_active Expired - Fee Related
- 2004-04-07 US US10/551,510 patent/US20060199841A1/en not_active Abandoned
- 2004-04-07 PL PL04726223T patent/PL1610785T3/pl unknown
- 2004-04-07 JP JP2006506245A patent/JP2006522786A/ja not_active Withdrawn
- 2004-04-07 WO PCT/HU2004/000032 patent/WO2004089352A2/en not_active Ceased
- 2004-04-07 DK DK04726223T patent/DK1610785T3/da active
- 2004-04-07 EA EA200501591A patent/EA007732B1/ru not_active IP Right Cessation
- 2004-04-07 HR HR20070441T patent/HRP20070441T3/xx unknown
2005
- 2005-11-08 NO NO20055254A patent/NO20055254L/no not_active Application Discontinuation
2007
- 2007-10-02 CY CY20071101259T patent/CY1106903T1/el unknown

Also Published As

Publication number	Publication date
DE602004008440T2 (de)	2008-05-21
EP1610785A2 (en)	2006-01-04
WO2004089352A3 (en)	2004-12-16
HUP0300929A3 (en)	2005-06-28
HUP0300929A2 (hu)	2005-02-28
US20060199841A1 (en)	2006-09-07
EP1610785B1 (en)	2007-08-22
CY1106903T1 (el)	2012-09-26
DK1610785T3 (da)	2007-10-22
HUP0300929D0 (en)	2003-06-28
NO20055254L (no)	2006-01-06
JP2006522786A (ja)	2006-10-05
NO20055254D0 (no)	2005-11-08
WO2004089352A2 (en)	2004-10-21
EA007732B1 (ru)	2006-12-29
ATE370733T1 (de)	2007-09-15
PT1610785E (pt)	2007-09-10
HRP20070441T3 (hr)	2007-10-31
RS20050738A (sr)	2008-04-04
ES2293245T3 (es)	2008-03-16
DE602004008440D1 (de)	2007-10-04
EA200501591A1 (ru)	2006-06-30

Publication	Publication Date	Title
AP1822A (en)	2008-01-30	Substituted pyridinones as modulators of P38 MAP kinase.
GB0022438D0 (en)	2000-11-01	Organic Compounds
TW200615266A (en)	2006-05-16	Organic compounds
MY148480A (en)	2013-04-30	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TNSN04203A1 (en)	2007-03-12	Benzoxazinone-derived compounds, their preparation and use as medicaments
UA85708C2 (ru)	2009-02-25	Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
TW200621737A (en)	2006-07-01	2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
WO2005030766A8 (en)	2006-03-02	Phenyl - carboxamide compounds useful for treating pain
ZA200604410B (en)	2008-09-25	Imidazole derivatives, processes for preparing them and their uses
MXPA05013151A (es)	2006-03-17	3-fluoro-piperidinas como antagonistas de n-metil-d-aspartato/nr2b.
WO2003101382A3 (en)	2004-07-29	Compounds useful in the treatment of anthrax and inhibiting lethal factor
IL173377A0 (en)	2006-06-11	Compounds for the treatment of metabolic disorders
YU44202A (sh)	2005-11-28	Kvaternerne soli n-substituisanih cikiličnih ili ne- cikličnih amina kao farmaceutski preparati
MXPA02006051A (es)	2004-08-23	Compuestos de amonio cuaternario ciclico.
MY139228A (en)	2009-08-28	Imidazolinylmethyl aralkylsulfonamides
GB0212410D0 (en)	2002-07-10	Organic compounds
CY1106903T1 (el)	2012-09-26	Φαρμακευτικος συνδυασμος για τη θεραπεια της σπαστικοτητας και/ή του πονου
SI1970372T1 (sl)	2011-04-29	Soli 9-oksoakridin-10-ocetne kisline z 1-alkilamino-1-deoksi-polioli
MXPA05008711A (es)	2005-10-05	Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.
GB0012795D0 (en)	2000-07-19	Organic compounds
MY136965A (en)	2008-12-31	1,4-disubstituted piperidine compounds, their preparation and use as medicaments
MXPA04002640A (es)	2004-06-07	Esteres de analogos de 3-desoxi-vitamina d3.
TW200640464A (en)	2006-12-01	Pharmaceutical composition comprising phenoxazinium compounds as an active ingredient
GEP20084343B (en)	2008-03-25	Use of indole derivatives for the treatment of neuropathic pain
UA81405C2 (en)	2008-01-10	Substituted pyridinones as modulators of p38 map kinase